Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC
Clinical trial NCT03790228 · UNKNOWN
Trial details
- NCT number
- NCT03790228
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2020-10-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.